<?xml version="1.0" encoding="UTF-8"?>
<ref id="mdx698-B13">
 <label>13</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Aapro</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Rugo</surname>
    <given-names>H</given-names>
   </name>, 
   <name name-style="western">
    <surname>Rossi</surname>
    <given-names>G</given-names>
   </name>
  </person-group>
  <etal/>
  <article-title>A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy</article-title>. 
  <source>Ann Oncol</source>
  <year>2014</year>; 
  <volume>25</volume>(
  <issue>7</issue>): 
  <fpage>1328</fpage>â€“
  <lpage>1333</lpage>.
  <pub-id pub-id-type="pmid">24603643</pub-id>
 </mixed-citation>
</ref>
